Strosberg, J., El-Haddad, G., Wolin, E., Grande, E., & Krenning, E. (2017). Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
Citación estilo ChicagoStrosberg, Jonathan, Ghassan El-Haddad, Edward Wolin, Enrique Grande, y Eric Krenning. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. 2017.
Cita MLAStrosberg, Jonathan, et al. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. 2017.
Precaución: Estas citas no son 100% exactas.